Silver Book Fact

A study of Medicare beneficiaries with glaucoma showed that health care costs increased with degree of vision loss–ranging from $8,157 per year for no vision loss to $18,670 for blindness.

Bramely T, Peeples P, Walt J, Juhasz M, et al. Impact of Vision Loss on Costs and Outcomes in Medicare Beneficiaries with Glaucoma. Arch Ophthalmol. 2008; 126(6): 846-56. http://archopht.ama-assn.org/cgi/reprint/126/6/849.pdf

Reference

Title
Impact of Vision Loss on Costs and Outcomes in Medicare Beneficiaries with Glaucoma
Publication
Arch Ophthalmol
Publication Date
2008
Authors
Bramely T, Peeples P, Walt J, Juhasz M, et al
Volume & Issue
Volume 126, Issue 6
Pages
846-56
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Individuals with early-stage age-related macular degeneration (AMD) are almost 2 times more likely to have a stroke than those who do not have the eye disease.  
  • Based on estimates from 1997 data, around 115,583 visually impaired and 74,133 blind individuals who did not work, would have worked if they had been fully sighted.  
  • More than 2 million Americans age 50 and older have age-related macular degeneration (AMD)—2,069,403.  
  • The average direct cost of glaucoma treatment ranges from $623 per year for patients with early-stage glaucoma, to $2,511 per year for end-stage patients. Medication costs make up the largest…  
  • Around 824,000 Americans age 74 and older have diabetic retinopathy– 5% of the 74 and older population.